# SPIRIVA in Ususal Care

> **NCT00274079** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 395 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** SPIRIVA

## Key facts

- **NCT ID:** NCT00274079
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 395 (—)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274079, "SPIRIVA in Ususal Care". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00274079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*